{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:44:23Z","timestamp":1790264663907,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7154211"],"award-info":[{"award-number":["7154211"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81050025"],"award-info":[{"award-number":["81050025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.neuropharm.2015.01.030","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T22:58:35Z","timestamp":1423609115000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice"],"prefix":"10.1016","volume":"93","author":[{"given":"Zhili","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.01.030_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2006.07.006","article-title":"Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease","volume":"159","author":"Allbutt","year":"2007","journal-title":"J.\u00a0Neurosci. Methods"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.neuropharm.2015.01.030_bib2","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/S1353-8020(09)70812-0","article-title":"Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease","volume":"15","author":"Beal","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1042\/BST20130234","article-title":"Mitochondrial trafficking in neurons and the role of the Miro family of GTPase proteins","volume":"41","author":"Birsa","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1601-183X.2007.00342.x","article-title":"Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?","volume":"7","author":"Bogaerts","year":"2008","journal-title":"Genes. Brain Behav."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib5","doi-asserted-by":"crossref","first-page":"31449","DOI":"10.1074\/jbc.M802552200","article-title":"Direct binding of GTP cyclohydrolase and tyrosine hydroxylase: regulatory interactions between key enzymes in dopamine biosynthesis","volume":"283","author":"Bowling","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/BJ20101561","article-title":"Divergence in enzyme regulation between Caenorhabditis elegans and human tyrosine hydroxylase, the key enzyme in the synthesis of dopamine","volume":"434","author":"Calvo","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib7","first-page":"1","article-title":"Emerging role of mitochondria dysfunction in the onset of neurodegenerative diseases","volume":"27","author":"Cavallucci","year":"2013","journal-title":"J.\u00a0Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1083\/jcb.201302040","article-title":"Kinesin-1-syntaphilin coupling mediates activity-dependent regulation of axonal mitochondrial transport","volume":"202","author":"Chen","year":"2013","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-62703-444-9_6","article-title":"Preparation of primary cultured dopaminergic neurons from mouse brain","volume":"1018","author":"Choi","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","article-title":"Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism","volume":"104","author":"Cleren","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib12","first-page":"347","article-title":"Drugs for Parkinson's disease","volume":"19","author":"Cranwell-Bruce","year":"2010","journal-title":"Medsurg Nurs."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12035-010-8150-4","article-title":"Mitochondrial quality control and Parkinson's disease: a pathway unfolds","volume":"43","author":"de Castro","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib15","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S1462399410001456","article-title":"Mitochondrial quality control and neurological disease: an emerging connection","volume":"12","author":"de Castro","year":"2010","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nm.1868","article-title":"Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease","volume":"14","author":"Du","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.biocel.2010.01.004","article-title":"Mitochondrial medicine for neurodegenerative diseases","volume":"42","author":"Du","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib18","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1523\/JNEUROSCI.23-15-06181.2003","article-title":"Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons","volume":"23","author":"Gao","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.55782\/ane-2013-1931","article-title":"Integrated pathways of parkin control over mitochondrial maintenance - relevance to Parkinson's disease pathogenesis","volume":"73","author":"Gaweda-Walerych","year":"2013","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib20","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.0737556100","article-title":"Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants","volume":"100","author":"Greene","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuron.2005.06.027","article-title":"The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses","volume":"47","author":"Guo","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mds.25032","article-title":"Pathogenesis of Parkinson's disease","volume":"28","author":"Hirsch","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib23","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1096\/fj.03-0240fje","article-title":"Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants","volume":"17","author":"Jauslin","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuint.2005.09.002","article-title":"Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease","volume":"48","author":"Kasparova","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib25","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.0711-11.2011","article-title":"The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons","volume":"31","author":"Kim-Han","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib27","first-page":"270","article-title":"Experimental modeling of functional deficiency of the nigrostriatal dopaminergic system in mice","volume":"96","author":"Kozina","year":"2010","journal-title":"Ross. Fiziol. Zh Im. I M. Sechenova"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.addr.2009.07.016","article-title":"The failure of mitochondria leads to neurodegeneration: do mitochondria need a jump start?","volume":"61","author":"Lee","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib29","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/ars.2011.4105","article-title":"Mitochondrial dynamics and Parkinson's disease: focus on parkin","volume":"16","author":"Lim","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10284150500047161","article-title":"Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease","volume":"8","author":"Liu","year":"2005","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbamcr.2012.04.007","article-title":"The meaning of mitochondrial movement to a neuron's life","volume":"1833","author":"Lovas","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbadis.2009.07.009","article-title":"The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy","volume":"1802","author":"Martin","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib34","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1523\/JNEUROSCI.6248-09.2010","article-title":"Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro\/Milton complex","volume":"30","author":"Misko","year":"2010","journal-title":"J.\u00a0Neurosci."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2015.01.030_bib35","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.3233\/JAD-2010-100345","article-title":"Mitochondria dysfunction and neurodegenerative disorders: cause or consequence","volume":"20","author":"Morais","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib36","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/hmg\/dds011","article-title":"Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria","volume":"21","author":"Morotz","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1242\/dmm.003178","article-title":"Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila","volume":"2","author":"Park","year":"2009","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib39","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.1073\/pnas.1216197110","article-title":"Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan","volume":"110","author":"Rana","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib40","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2013.12.042","article-title":"Activity-driven local ATP synthesis is required for synaptic function","volume":"156","author":"Rangaraju","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cub.2014.02.025","article-title":"Axons degenerate in the absence of mitochondria in C.\u00a0elegans","volume":"24","author":"Rawson","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12017-008-8044-z","article-title":"Mitochondrial medicine for aging and neurodegenerative diseases","volume":"10","author":"Reddy","year":"2008","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib43","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1523\/JNEUROSCI.5417-08.2009","article-title":"Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport","volume":"29","author":"Russo","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nbd.2014.06.014","article-title":"Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease","volume":"70","author":"Sanders","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib45","first-page":"2095","article-title":"The axonal transport of mitochondria","volume":"125","author":"Saxton","year":"2012","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib49","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1523\/JNEUROSCI.0529-10.2010","article-title":"Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia","volume":"30","author":"Shidara","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-61779-536-7_9","article-title":"Culture and characterization of rat mesencephalic dopaminergic neurons","volume":"846","author":"Skaper","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-2009-1095","article-title":"The neurodegenerative mitochondriopathies","volume":"17","author":"Swerdlow","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib53","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2174\/092986709788186200","article-title":"Rhodanine as a privileged scaffold in drug discovery","volume":"16","author":"Tomasic","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-59745-178-9_26","article-title":"FM 1-43 labeling of synaptic vesicle pools at the Drosophila neuromuscular junction","volume":"440","author":"Verstreken","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbadis.2011.03.007","article-title":"PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons","volume":"1812","author":"Wang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib56","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1471-4159.2001.00271.x","article-title":"Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells","volume":"77","author":"Wang","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib57","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cell.2011.10.018","article-title":"PINK1 and Parkin target miro for phosphorylation and degradation to arrest mitochondrial motility","volume":"147","author":"Wang","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2015.01.030_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-4695(19990605)39:3<337::AID-NEU1>3.0.CO;2-9","article-title":"Nitric oxide and cyclic GMP induce vesicle release at Drosophila neuromuscular junction","volume":"39","author":"Wildemann","year":"1999","journal-title":"J.\u00a0Neurobiol."},{"key":"10.1016\/j.neuropharm.2015.01.030_bib59","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.bbadis.2010.07.014","article-title":"New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease","volume":"1802","author":"Xie","year":"2010","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:54:36Z","timestamp":1762214076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":59,"alternative-id":["S0028390815000465"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.01.030","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}